Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors: guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Infectious complications are a significant cause of morbidity and mortality in patients with malignancies specifically when receiving anticancer treatments. Prevention of infection through vaccines is an important aspect of clinical care of cancer patients. Immunocompromising effects of the underlyi...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Körperschaft: | |
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 April 2018
|
| In: |
Annals of oncology
Year: 2018, Jahrgang: 29, Heft: 6, Pages: 1354-1365 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdy117 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1093/annonc/mdy117 Verlag: http://www.sciencedirect.com/science/article/pii/S0923753419348975 |
| Verfasserangaben: | C. T. Rieger, B. Liss, S. Mellinghoff, D. Buchheidt, O. A. Cornely, G. Egerer, W. J. Heinz, M. Hentrich, G. Maschmeyer, K. Mayer, M. Sandherr, G. Silling, A. Ullmann, M. J. G. T. Vehreschild, M. von Lilienfeld-Toal, H. H. Wolf, N. Lehners |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1690035412 | ||
| 003 | DE-627 | ||
| 005 | 20230427014607.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200214s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdy117 |2 doi | |
| 035 | |a (DE-627)1690035412 | ||
| 035 | |a (DE-599)KXP1690035412 | ||
| 035 | |a (OCoLC)1341305388 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 110 | 2 | |a Deutsche Gesellschaft für Hämatologie und Onkologie |b Arbeitsgemeinschaft Infektiologie |e VerfasserIn |0 (DE-588)5320980-1 |0 (DE-627)267779267 |0 (DE-576)197598188 |4 aut | |
| 245 | 1 | 0 | |a Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors |b guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) |c C. T. Rieger, B. Liss, S. Mellinghoff, D. Buchheidt, O. A. Cornely, G. Egerer, W. J. Heinz, M. Hentrich, G. Maschmeyer, K. Mayer, M. Sandherr, G. Silling, A. Ullmann, M. J. G. T. Vehreschild, M. von Lilienfeld-Toal, H. H. Wolf, N. Lehners |
| 264 | 1 | |c 24 April 2018 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.02.2020 | ||
| 520 | |a Infectious complications are a significant cause of morbidity and mortality in patients with malignancies specifically when receiving anticancer treatments. Prevention of infection through vaccines is an important aspect of clinical care of cancer patients. Immunocompromising effects of the underlying disease as well as of antineoplastic therapies need to be considered when devising vaccination strategies. This guideline provides clinical recommendations on vaccine use in cancer patients including autologous stem cell transplant recipients, while allogeneic stem cell transplantation is subject of a separate guideline. The document was prepared by the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) by reviewing currently available data and applying evidence-based medicine criteria. | ||
| 650 | 4 | |a anti-infective vaccination | |
| 650 | 4 | |a autologous stem cell transplantation | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a immunosuppression | |
| 650 | 4 | |a infection | |
| 700 | 1 | |a Rieger, Christina |d 1975- |e VerfasserIn |0 (DE-588)124900690 |0 (DE-627)367769875 |0 (DE-576)294559108 |4 aut | |
| 700 | 1 | |a Buchheidt, Dieter |d 1955- |e VerfasserIn |0 (DE-588)1028287461 |0 (DE-627)730538621 |0 (DE-576)375787380 |4 aut | |
| 700 | 1 | |a Egerer, Gerlinde |e VerfasserIn |0 (DE-588)105502168X |0 (DE-627)792516745 |0 (DE-576)167430882 |4 aut | |
| 700 | 1 | |a Giesen, Nicola |d 1983- |e VerfasserIn |0 (DE-588)141844272 |0 (DE-627)631828524 |0 (DE-576)32643657X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 29(2018), 6, Seite 1354-1365 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) |
| 773 | 1 | 8 | |g volume:29 |g year:2018 |g number:6 |g pages:1354-1365 |g extent:12 |a Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) |
| 856 | 4 | 0 | |u https://doi.org/10.1093/annonc/mdy117 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0923753419348975 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20200214 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 141844272 |a Giesen, Nicola |m 141844272:Giesen, Nicola |d 910000 |d 910100 |e 910000PG141844272 |e 910100PG141844272 |k 0/910000/ |k 1/910000/910100/ |p 17 |y j | ||
| 998 | |g 105502168X |a Egerer, Gerlinde |m 105502168X:Egerer, Gerlinde |d 910000 |d 910100 |e 910000PE105502168X |e 910100PE105502168X |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1028287461 |a Buchheidt, Dieter |m 1028287461:Buchheidt, Dieter |d 60000 |d 61200 |e 60000PB1028287461 |e 61200PB1028287461 |k 0/60000/ |k 1/60000/61200/ |p 4 | ||
| 999 | |a KXP-PPN1690035412 |e 359531817X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"recId":"320428796","pubHistory":["1.1990 -"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"disp":"Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)Annals of oncology","title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"6","extent":"12","year":"2018","text":"29(2018), 6, Seite 1354-1365","pages":"1354-1365","volume":"29"},"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1569-8041"],"zdb":["2003498-2"],"eki":["320428796"]},"language":["eng"],"origin":[{"dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press"}]}],"corporate":[{"role":"aut","display":"Deutsche Gesellschaft für Hämatologie und Onkologie"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"id":{"doi":["10.1093/annonc/mdy117"],"eki":["1690035412"]},"physDesc":[{"extent":"12 S."}],"person":[{"given":"Christina","family":"Rieger","display":"Rieger, Christina","role":"aut"},{"role":"aut","display":"Buchheidt, Dieter","family":"Buchheidt","given":"Dieter"},{"role":"aut","given":"Gerlinde","display":"Egerer, Gerlinde","family":"Egerer"},{"role":"aut","display":"Giesen, Nicola","family":"Giesen","given":"Nicola"}],"title":[{"subtitle":"guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)","title":"Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors","title_sort":"Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors"}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"24 April 2018"}],"recId":"1690035412","note":["Gesehen am 14.02.2020"],"name":{"displayForm":["C. T. Rieger, B. Liss, S. Mellinghoff, D. Buchheidt, O. A. Cornely, G. Egerer, W. J. Heinz, M. Hentrich, G. Maschmeyer, K. Mayer, M. Sandherr, G. Silling, A. Ullmann, M. J. G. T. Vehreschild, M. von Lilienfeld-Toal, H. H. Wolf, N. Lehners"]}} | ||
| SRT | |a DEUTSCHEGEANTIINFECT2420 | ||